Neoplasms Malignant Completed Phase 1 Trials for Cabazitaxel (DB06772)

Also known as: Neoplasm Malignant / Malignant Tumors / Malignant Tumor / Cancer / Malignant neoplasm NOS / Cancer NOS / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

DBCOND0047288 (Neoplasms Malignant)Completed1 IdentifierTitlePurposeDrugs
NCT01087021Effect of Cabazitaxel on the QTc Interval in Cancer PatientsTreatment
NCT01527929Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal ImpairmentTreatment
NCT01140607Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver ImpairmentTreatment